Hey there, this is the default text for a new paragraph. Feel free to edit this paragraph by clicking on the yellow edit icon. After you are done just click on the yellow checkmark button on the top right. Have Fun!
System Design
Ozempic Access For Patients In US Healthcare System
Role
- System Thinking
- System Mapping
- Information Design
- Diagraming
Details
Team - Amulya Kaipa, Akshay Pagar, and Bhairavi Ruparel
Year - 2023
Project Scope
The project aims to investigate the evolving distribution dynamics of Ozempic, a glucagon-like peptide-1 (GLP-1) receptor agonist. This includes a detailed analysis of the systemic changes highlighted on the system map, particularly the shift towards weight loss patients and away from diabetic patients. The scope extends to identifying key stakeholders in the supply chain and analyzing their roles, thereby understanding how this shift has created a conundrum within the distribution network. Additionally, the investigation encompasses quality and consistency concerns, focusing on the involvement of compound pharmacies outside regulated environments in Ozempic distribution. Moreover, the scope includes an analysis of the current US patent system's influence on Ozempic pricing, specifically on Novo Nordisk's control, and exploring concerns related to affordability and equity in healthcare, especially their potential disproportionate impact on vulnerable populations.
Approach
The project's approach involves a systematic methodology to gather relevant data and insights. The data collection phase focuses on the distribution patterns of Ozempic, with specific attention to recent shifts toward weight loss. Additionally, information on compound pharmacies engaged in Ozempic distribution will be collected, assessing their regulatory compliance and practices. The subsequent analysis will consider Novo Nordisk's pricing control over Ozempic and its implications for patient access. Stakeholders and key players in the pharmaceutical supply chain are essential to gaining insights into the reasons behind the distribution shift and its safety implications. The project concludes with a comprehensive system map, with an overarching goal to provide recommendations and interventions that ensure patient safety, promote ethical distribution practices, and address pricing disparities in Ozempic utilization.
